Tg(Vav1-NUP98/HOXD13)C1Apla
Transgene Detail
|
Symbol: |
Tg(Vav1-NUP98/HOXD13)C1Apla |
Name: |
transgene insertion C1, Peter Aplan |
MGI ID: |
MGI:4357688 |
Synonyms: |
NHD13 tg |
Transgene: |
Tg(Vav1-NUP98/HOXD13)C1Apla Location: unknown
|
Alliance: |
Tg(Vav1-NUP98/HOXD13)C1Apla page
|
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(Vav1-NUP98/HOXD13)C1Apla expresses
2 genes
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
HOXD13 (3239) |
|
|
human |
NUP98 (4928) |
|
|
|
|
|
Mutation details: A transgenic construct containing cDNA of the amino-terminal region of the human nucleoporin 98kDa (NUP98) fused to the homeodomain of the human homeobox D13 (HOXD13) under the control of the 3' and 5' mouse vav 1 oncogene (Vav1) regulatory elements and SV40 polyadenylation site sequence was injected into fertilized FVB/N mouse eggs. Five founders were obtained but only 1 line, C1, transmitted the transgene. Founder line C1 was subsequently established. Expression is detected in hematopoietic tissues, such as thymus, spleen, and bone marrow, but not in nonhematopoietic tissues like brain, kidney, and liver.
(J:107446)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:107446 Lin YW, et al., NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia. Blood. 2005 Jul 1;106(1):287-95 |
All: |
21 reference(s) |
|